Gamze Muz
Nevşehir, 50300, Turkey (Türkiye)
NCT Number: NCT04052906
This study aims to evaluate the effect of planned inhaler medication training on self-care agency and self-efficacy level.
Looking for future studies?
Notify Me18 year–99 year
All sexes
Interventional
Not applicable
Nevşehir, 50300, Turkey (Türkiye)
Pulmonary diseases are a major source of mortality and morbidity globally. The major symptom of COPD is dyspnea. Since dyspnea leads to activity limitation and inadequate self-care skills among individuals, it is often associated with major psychological comorbidity, social isolation and poor perceived quality of life. COPD patients with high self-efficacy are high enough to level of treatment adherence. On the other hand, the most preferred treatment method for the management and mitigation of COPD symptoms is by the use of inhaler medication. However, incorrect use of the inhaler would lead to failure in the control of COPD patients. Also, it fails to provide COPD patients with self-care agency and self-efficacy levels. In COPD, planned inhaler medication training has been shown in many studies to reduce dyspnoea, increase self-care and self-efficacy levels. Therefore, planned inhaler medication training increases quality of life in COPD patients.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Planned Inhaler Medication Trainning
Time frame: baseline to the 3 months after intervention
CSES developed by Wigal et al. (1991) is used to determine the degree of confidence that COPD patients have in managing or avoiding breathing difficulty during certain activities. The scale consists of 34 items and 5 subscales.
Time frame: baseline to the 3 months after intervention
The Self-care Agency Scale (1979) was developed by Kearney and Fleischer, and its validity and reliability study in Turkey was conducted by Nahcivan in 1993. With this scale consisting of 35 items, patients evaluate their ability or agency to perform self-care actions.
Time frame: baseline to the 3 months after intervention
While the Modified Borg Scale is nowadays generally used to define the severity of dyspnea in exercise, it can also be used to assess the severity of resting dyspnea
Time frame: baseline to the 3 months after intervention
The dyspnea scale is a 1 to 5 score scale consisting of five items based on various physical activities that produce a feeling of dyspnea.
Nevsehir Haci Bektas Veli University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05412160
Amino Acid Metabolism, Inborn Errors, Argininemia
Milan, Italy
View Trial DetailsNCT04997200
COPD, Chronic Disease
Karlskrona, Blekinge County, Sweden
View Trial DetailsNCT03442140
COPD, Chronic Disease
Dallas, Texas, United States
View Trial DetailsNCT04868357
Anxiety, Anxiety Disorders
Briis-sous-Forges, France
View Trial Details